SciELO - Scientific Electronic Library Online

 
vol.69 número1Ooforosalpingitis xantogranulomatosa. Comunicación de caso índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

  • Não possue artigos citadosCitado por SciELO

Links relacionados

  • Não possue artigos similaresSimilares em SciELO

Compartilhar


Revista Peruana de Ginecología y Obstetricia

versão On-line ISSN 2304-5132

Rev. peru. ginecol. obstet. vol.69 no.1 Lima jan./mar. 2023  Epub 27-Mar-2023

http://dx.doi.org/10.31403/rpgo.v69i2490 

Letter to the editor

Epidemiological status of perinatal and late neonatal mortality in Colombia, 2022

Juan Santiago Serna-Trejos1 
http://orcid.org/0000-0002-3140-8995

Stefanya Geraldine Bermúdez-Moyano2 
http://orcid.org/0000-0002-2259-6517

1Departamento de Epidemiología, Universidad Libre - Seccional Cali, Cali, Colombia. Departamento de Docencia Universitaria, Universidad Piloto Bogotá, Colombia. Instituto Nacional de Salud, Bogotá, Colombia. Grupo interdisciplinario de investigación en epidemiología y salud pública, Cali, Colombia. Hospital Universitario del Valle, Unidad de Cuidado Intensivo, Cali. Colombia.

2Hospital Universitario del Valle, Unidad de Cuidado Intensivo, Cali. Colombia.

Dear Editor:

Late perinatal and neonatal mortality (LPNM) is an event of high public health interest, not only in Colombia, but globally. Perinatal mortality is defined as death occurring from the 22nd completed week of gestation or 500 grams or more of fetal weight up to 7 days after birth, and directly relates to those live births that die during the first 28 full days of life. Neonatal death is divided into early neonatal deaths, which occur during the first 7 days, and late neonatal deaths, which occur from day 7 of birth through day 28 of life. The importance of a timely and effective analysis of this perinatal mortality indicator is related to a direct and indirect analysis of causes related to reproduction, access to health care, biological, social, and maternal health conditions1).

For the year 2022, approximately 7,085 cases of LPNM were registered in Colombia, representing a decrease of 13.2% of cases compared to the year 2021. The ratio of LPNM deaths in Colombia is 12.9 per 1000 live births, 94% of which have a well-defined cause of death2).

The time of occurrence of fetal death was antepartum in 46% (3,307 cases). The mortality ratio by health system affiliation was 9.5 cases per 1,000 uninsured live births. The ratio of LPNM deaths by area of residence is of concern, given that in dispersed rural areas LPNM mortality was 12.1 cases per 1,000 live births. In relation to ethnicity, mortality was 17.8 cases per 1,000 live births in the indigenous population2).

The age of the mother was a relevant factor. In Colombia, maternal population groups were recorded whose age ranged from 40 years of age and older, with 26.1 cases per 1,000 live births (371 cases), followed by the other end of the population, the age group between 10-14 years, with 21.1 cases per 1,000 live births (91 cases)2).

The main causes of death identified in LPNM were prematurity-immaturity, which accounted for 3 cases per 1,000 live births (1,673 cases), followed by asphyxia and related causes, which accounted for 2.9 cases per 1,000 live births (1,577 cases). Infections were responsible for 11% of all LPNM cases, accounting for 1.4 cases per 1,000 live births (778 cases). Congenital malformations registered 1 case per 1,000 live births, representing 8.1% of the LPNMs.

The territorial entities in Colombia with the highest mortality rates were Chocó (29.2 cases of LPNM per 1,000 live births) Amazonas (20.4 cases of LPNM per 1,000 live births) and Vaupés (19.9 cases of LPNM per 1,000 live births)2).

Another variable of interest taken by the National Institute of Health (NIH) and the National Public Health Surveillance System (SIVIGILA, by its initials in Spanish) was related to the behavior of SARS-CoV-2 infection in neonates. In 2022, 637 cases of COVID-19 were registered, of which 1.6% were active and 97.8% were considered recovered cases (623 cases). No neonatal deaths due to SARS-CoV-2 have been reported to date in Colombia. The sex most affected was male, with 56.7% of the cases (361 cases). It is presumed that the source of SARS-CoV-2 infection in neonates in Colombia was the community in 91.8% (585 cases), related to mild stages of the disease in 97% (623 cases), where only 0.5% progressed to severe stages (3 cases) without deaths2).

The analysis of this indicator makes it necessary to create public health policies aimed at generating a significant impact on its reduction and on the optimization of the different health services for pregnant women. In Colombia, strategies have been established aimed at complying with the policies adopted by the Pan American Health Organization (PAHO) of the campaign ‘28 days, time to care and love’3). Created through resolution 3,280 of 20184), it is a strategy capable of strengthening the general social security health system to improve access and guarantee quality care for this vulnerable population group5-7).

REFERENCES

1. Bhattarai SKG, Ghimire R, Duwadi S, Khadka R, Gautam K. Perinatal Mortality among All Deliveries in a Tertiary Care Center: A Descriptive Cross-sectional Study. J Nepal Med Assoc [Internet]. 2021;59(243):1075-80. doi:10.31729JNMA.6691 [ Links ]

2. Instituto Nacional de Salud. Informe de evento: Mortalidad Perinatal y Neonatal tardía en Colombia. Inf Even [Internet]. 2022;30. https://www.ins.gov.co/buscador-eventos/BoletinEpidemiologico/2019 Boletínepidemiológicosemana 12.pdfLinks ]

3. OPS. Campaña de los 28 días Salud del recién nacido OPS/OMS | Organización Panamericana de la Salud [Internet]. 2016. https://www.paho.org/es/campanas/campana-28-dias-salud-recien-nacidoLinks ]

4. Ministerio de Salud y la Protección Social. Ministerio de Salud y Protección Social Resolución 3280 de 2018. Resolución 3280 [Internet]. 2018;1-348. https://www.minsalud.gov.co/Normatividad_Nuevo/ResoluciónNo.3280de20183280.pdf%0Ahttps://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/DE/DIJ/resolucion-3280-de-2018.pdfLinks ]

5. Nijkamp JW, Sebire NJ, Bouman K, Korteweg FJ, Erwich JJHM, Gordijn SJ. Perinatal death investigations: What is current practice? J.W. Semin Fetal Neonatal Med [Internet]. 2017;22(January):167-75. doi:10.1016/j.siny.2017.02.005 [ Links ]

6. Baliga S. Perinatal Death Auditing is Necessary to Identify Preventable Perinatal Deaths. Int J Prev Med [Internet]. 2022;13:48. doi:10.4103/ijpvm.IJPVM_65_20 [ Links ]

7. Kinney MV, Walugembe DR, Wanduru P, Waiswa P, George Maternal and perinatal death surveillance and response in lowand middle-income countries: A scoping review of implementation factors. Health Policy Plan [Internet]. 2021;36(6):955-73. doi:10.1093/heapol/czab011 [ Links ]

Funding: Self-funded

Authorship contribution: All authors have contributed to the conception, drafting of the final manuscript, revision and approval of the manuscript

Cite as: Serna-Trejos JS, Bermúdez-Moyano SG. Epidemiological status of perinatal and late neonatal mortality in Colombia, 2022. Letter to the Editor. Rev peru ginecol obstet. 2023;69(1). DOI: https://doi.org/10.31403/rpgo.v69i2490

Received: January 14, 2023; Accepted: January 30, 2023

Conflicts of interest:

The authors declare no conflicts of interest

Creative Commons License Este es un artículo publicado en acceso abierto bajo una licencia Creative Commons